0001614744 2026-05-20 2026-05-20 0001614744 1 2026-05-20 2026-05-20 0001614744 2 2026-05-20 2026-05-20 0001614744 3 2026-05-20 2026-05-20 0001614744 4 2026-05-20 2026-05-20 0001614744 5 2026-05-20 2026-05-20 0001614744 6 2026-05-20 2026-05-20 0001614744 7 2026-05-20 2026-05-20 0001614744 8 2026-05-20 2026-05-20 0001614744 9 2026-05-20 2026-05-20 0001614744 10 2026-05-20 2026-05-20 0001614744 11 2026-05-20 2026-05-20 0001614744 12 2026-05-20 2026-05-20 0001614744 13 2026-05-20 2026-05-20 0001614744 14 2026-05-20 2026-05-20 0001614744 15 2026-05-20 2026-05-20 0001614744 16 2026-05-20 2026-05-20 iso4217:USD pure F-3 F-3 EX-FILING FEES 0001614744 PURPLE BIOTECH LTD. N/A N/A 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 F-3 PURPLE BIOTECH LTD. Equity Ordinary Shares, no par value per share true Equity Preferred Shares, no par value per share true Other Warrants true Other Overallotment Purchase Rights true Other Subscription Rights true Other Units true Debt Capital Notes true false Unallocated (Universal) Shelf true 15565700.05 0.0001381 2149.62 Equity Ordinary Shares, no par value per share true F-3 333-268710 2023-05-22 Equity Preferred Shares, no par value per share true F-3 333-268710 2023-05-22 Other Warrants true F-3 333-268710 2023-05-22 Other Overallotment Purchase Rights true F-3 333-268710 2023-05-22 Other Subscription Rights true F-3 333-268710 2023-05-22 Other Units true F-3 333-268710 2023-05-22 Debt Capital Note true F-3 333-268710 2023-05-22 Unallocated (Universal) Shelf true 184434299.95 F-3 333-268710 2023-05-22 21031.44 200000000.00 2149.62 0.00 0.00 2149.62 The ordinary shares registered hereby may be represented by American depositary shares (ADSs). ADSs evidenced by American depositary receipts issuable upon deposit of the ordinary shares registered hereby have been registered pursuant to a separate registration statement on Form F-6 (File No. 333-207858). Each ADS represents 2,000 ordinary shares. Pursuant to Rule 416 of the Securities Act, this Registration Statement also includes additional ordinary shares issuable upon stock splits, stock dividends or similar transactions. These offered securities may be sold separately, together or as units with other offered securities. An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices. Pursuant to Rule 457(o) under the Securities Act, which permits the registration fee to be calculated on the basis of the maximum offering price of all the securities listed, the table does not specify by each class information as to the amount to be registered, proposed maximum offering price per unit or proposed maximum aggregate offering price. The aggregate public offering price of securities sold by the Registrant (including newly listed securities and carry-forward securities) will not exceed $200,000,000 The Registrant previously registered $200,000,000 in aggregate offering price of securities pursuant to the Registration Statement on Form F-3 (File No. 333-268710) filed on December 8, 2022, and declared effective on May 22, 2023 (the "Prior Registration Statement"), $184,434,299.95 of which remains unsold as of the date of filing of this registration statement (the "Unsold Securities"). The Registrant expects to carry forward to this registration statement the Unsold Securities pursuant to Rule 415(a)(6) under the Securities Act of 1933, as amended. The Registrant previously carried forward a registration fee of $15,584.14 in connection with the filing of the Prior Registration Statement of which $14,370.99 relates to the Unsold Securities. The $14,370.99 previously paid filing fee relating to such Unsold Securities under the Prior Registration Statement will continue to be applied to such Unsold Securities registered on this registration statement. For reasons stated above, the net registration fee paid in connection with the Unsold Securities is $0. To the extent that, after the filing date hereof and prior to the effectiveness of this registration statement, the Registrant sells any Unsold Securities pursuant to the Prior Registration Statement, the Registrant will identify in a pre-effective amendment to this registration statement the updated amount of Unsold Securities from the Prior Registration Statement to be included in this registration statement pursuant to Rule 415(a)(6). Pursuant to Rule 415(a)(6), the offering of the Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement. To the extent that, after the filing date hereof and prior to the effectiveness of this registration statement, the Registrant sells any Unsold Securities pursuant to the Prior Registration Statement, the Registrant will identify in a pre-effective amendment to this registration statement the updated amount of Unsold Securities from the Prior Registration Statement to be included in this registration statement pursuant to Rule 415(a)(6). Pursuant to Rule 415(a)(6), the offering of the Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement.